Publication of exemption document in relation to the proposed combination of Novozymes and Chr. Hansen, confirmation of outlook for 2023 and proposed candidates to the Board of Directors of the combined companyGlobeNewsWire • 03/08/23
Novozymes and Chr. Hansen receive binding tax ruling that the proposed merger can be completed as a tax-exempt mergerGlobeNewsWire • 01/24/23
Carbios and Novozymes Strengthen Collaboration With Long-Term Exclusive Strategic Partnership to Secure Worldwide Leadership in Biorecycling of PETBusiness Wire • 01/12/23
Novozymes and Chr. Hansen to combine and create a leading global biosolutions partnerGlobeNewsWire • 12/12/22
As one of the first companies in the world, Novozymes has had its net-zero target validated by the Science Based Targets initiativeGlobeNewsWire • 11/10/22
Novozymes and LinusBio announce collaboration to accelerate scientific discovery in BiohealthGlobeNewsWire • 11/10/22
Novozymes Named EPA Safer Choice Partner of the Year for Second Consecutive YearGlobeNewsWire • 11/01/22
Novozymes A/S (NVZMF) CEO Ester Baiget on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/11/22
Novozymes delivers strong half year results and narrows full-year outlook upwardsGlobeNewsWire • 08/11/22
Novozymes plan to further increase prices across the portfolio in response to the significant and persistent hike in incoming costGlobeNewsWire • 07/15/22